Altre lingue Kidswell Bio Corporation

Azioni

4584

JP3386460004

Tempo differito Japan Exchange Altri mercati azionari 04:00:36 17/07/2024			Variaz. 5gg	Var. 1 gen.
148 ^JPY	+3,50%		+10,45%	+10,45%

2022	L'indice giapponese riduce i guadagni a causa delle pressioni inflazionistiche; Dena acquisisce una partecipazione di maggioranza nel business ICT mobile per 230 milioni di dollari.	MT
2021	Kidswell Bio Corporation riporta i risultati degli utili per il semestre conclusosi il 30 settembre 2021	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Kidswell Bio Corporation announced that it has received ¥22.8 million in funding from CVI Investments, Inc.	26/07/23
Kidswell Bio Corporation announced that it expects to receive Â¥22.8 million in funding from CVI Investments, Inc.	10/07/23
Kidswell Bio Corporation(TSE:4584) dropped from S&P Global BMI Index	19/09/22
Japan Index Trims Gains over Inflationary Pressures; Dena to Take Majority Stake in Mobile ICT Business for $230 Million	27/05/22
Chiome Bioscience, Kidswell Bio to Collaborate on Development of Cancer Antibody	27/05/22
Kidswell Bio Corporation Reports Earnings Results for the Half Year Ended September 30, 2021	05/11/21
Kidswell Bio Corporation(TSE:4584) added to S&P Global BMI Index	20/09/21
Gene Techno Science : Announcement of Joint Research Agreement with Hokkaido University and Spinal Injuries Center for Non-Union Fractures	21/08/20
Gene Techno Science Co.,Ltd. Reports Earnings Results for the Year Ended March 2020	17/07/20
Dojin Group Co., Ltd. entered into a share transfer agreement to acquire Advanced Cell Technology and Engineering Ltd. from Gene Techno Science Co.,Ltd. for ¥0.	10/07/20
Gene Techno Science : Announcement of completion of issuance of the 3rd series of convertible bond with stock acquisition rights	09/04/20
Gene Techno Science Co.,Ltd. announced that it has received ¥604.852632 million in funding from CVI Investments, Inc.	08/04/20
Gene Techno Science Co.,Ltd. announced that it expects to receive ¥604.852632 million in funding from CVI Investments, Inc.	23/03/20
Gene Techno Science Enters into Research Agreement with Nagoya University	07/03/20
Gene Techno Science Co., Ltd Has Executes A Joint Research Agreement with Oita University	07/03/20
Gene Techno Science Co.,Ltd. acquired remaining 94.7% stake in Japan Regenerative Medicine Co., Ltd. from Noritsu Koki Co., Ltd. for ¥0.	17/02/20
Gene Techno Science : Signed alliance agreement with Eil for business development in regenerative medicine and healthcare area	31/01/20
Gene Techno Science : Announcement of Joint Research Agreement for New Antibodies with MabGenesis Inc.	22/01/20
Gene Techno Science : Announcement of Joint Development Agreement of Aflibercept Biosimilars with Kishi Kasei Co., Ltd.	02/12/19
Gene Techno Science Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2020	05/11/19

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Kidswell Bio Corporation

Azioni

4584

JP3386460004

Altre lingue

Filtri